NEW YORK (TheStreet) — Fund managers are looking to finish strong in 2014 as well as set themselves up for a run in 2015 and beyond. Andrew Ver Planck, portfolio manager for the MainStay International Opportunities Fund, said one of his picks is Teva Pharmaceutical . The stock is up a compelling 43% in 2014 but there are worries about the company's multiple sclerosis treatment, he said. Right …
More: continued here
